CIA
ARRY

CSat Investment Advisory’s Array Biopharma Inc ARRY Stock Holding History

CSat Investment Advisory’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-475
Closed -$22K – 1079
2019
Q2 		$22K Buy
+475
New +$13.3K 0.01% 678

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

CSat Investment Advisory's ARRY Position: Q3 2019 in Review

CSat Investment Advisory sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 475 shares — an estimated $22K sold.

CSat Investment Advisory first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $22K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • CSat Investment Advisory reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • CSat Investment Advisory sold 475 Array Biopharma Inc shares in Q3 2019, an estimated $22K.
  • CSat Investment Advisory first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • CSat Investment Advisory's Array Biopharma Inc position peaked at $22K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on CSat Investment Advisory's 13F filing for Q3 2019, filed 14 Nov 2019.